CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Aug 3, 2026

Revenue (TTM)
$405.62B
+6.1% YoY
Gross margin
13.4%
EPS (latest q)
$2.57
vs $2.21 est · beat
52-wk position
89.1%
-5.0% vs 52w high · +0.3% 1mo

Price (last ~year)

CVS Health Corp reported first-quarter 2026 revenue of $100.43 billion and earnings per share of $2.57, marking its fourth consecutive quarter of beating analyst expectations. The company, which holds a market capitalization of $133.25 billion and trailing twelve-month revenue of $405.62 billion, carries $78.34 billion in total debt with a 5.1x debt-to-EBITDA ratio. Profit margins remain thin at 0.7%, while the stock has appreciated 30.2% over the last three months to a recent price of $104.43.

Valuation

Market cap
$133.25B
P/E
45.8
PEG
0.294
P/B
1.72
P/S
0.329
EV/EBITDA
17.95
Beta
0.598
Analyst target
$113.5

Quality & returns

Gross margin
13.4%
Operating margin
4.1%
Profit margin
0.7%
ROE
3.8%
ROA
2.7%

Price movement

Last
$104.43
1-month
+0.3%
3-month
+30.2%
RSI (14)
48
vs SMA200
+25.2%
52-wk position
89.1% -5.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B
2025-06-30$98.92B$2.38B$1.02B$3.58B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots